INFLIXIMAB; ANTI-TNF BLOCKER

Infliximab is a chimeric monoclonal antibody that targets tumor necrosis factor - alpha (TNF - alpha), a key pro - inflammatory cytokine involved in various autoimmune diseases.By binding to TNF - alpha, infliximab effectively blocks its interaction with cell surface receptors, thereby reducing inflammation and disease activity.This medication is used to treat a range of conditions including rheumatoid arthritis, Crohns disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis.nn 1 While infliximab has shown significant efficacy in managing these conditions, it is important to note that it may increase the risk of infections and other side effects, necessitating careful monitoring and management by healthcare professionals